| Date Filed | Type | Description |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/01/2021 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 01/29/2021 |
SC 13G
| JNE Partners LLP reports a 0% stake in Prevail Therapeutics Inc. |
| 01/27/2021 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 01/26/2021 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Unknown transaction of 13,822,463 shares
@ $0 |
|
| 01/26/2021 |
4
| Abeliovich Asa (President & CEO) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Unknown transaction of 2,385,756 shares
@ $0
Disposed/sold 1,329,219 options to buy
@ $0.18, valued at
$239.3k
Disposed/sold 178,681 options to buy
@ $10.26, valued at
$1.8M
Disposed/sold 250,000 options to buy
@ $16.91, valued at
$4.2M
|
|
| 01/26/2021 |
4
| Adams Timothy M (Director) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Disposed/sold 32,400 options to buy
@ $10.26, valued at
$332.4k
Disposed/sold 17,000 options to buy
@ $16.98, valued at
$288.7k
|
|
| 01/26/2021 |
4
| Carson William H. (Director) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Disposed/sold 34,000 options to buy
@ $11.11, valued at
$377.7k
|
|
| 01/26/2021 |
4
| Dai Yong (Chief Technology Officer) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Disposed/sold 200,172 options to buy
@ $0.18, valued at
$36k
Disposed/sold 126,567 options to buy
@ $10.26, valued at
$1.3M
Disposed/sold 43,500 options to buy
@ $16.91, valued at
$735.6k
|
|
| 01/26/2021 |
4
| Hefti Franz (Chief Development Officer) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Disposed/sold 266,895 options to buy
@ $0.18, valued at
$48k
Disposed/sold 59,844 options to buy
@ $10.26, valued at
$614k
Disposed/sold 62,200 options to buy
@ $16.91, valued at
$1.1M
|
|
| 01/26/2021 |
4
| Kaplan Brett (CFO) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Disposed/sold 347,004 options to buy
@ $0.18, valued at
$62.5k
Disposed/sold 64,565 options to buy
@ $10.26, valued at
$662.4k
Disposed/sold 95,000 options to buy
@ $16.91, valued at
$1.6M
|
|
| 01/26/2021 |
4
| Minkow Emily (Chief Business Officer) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Unknown transaction of 13,000 shares
@ $0
Disposed/sold 149,000 options to buy
@ $0.18, valued at
$26.8k
Disposed/sold 104,895 options to buy
@ $0.18, valued at
$18.9k
Disposed/sold 108,854 options to buy
@ $10.26, valued at
$1.1M
Disposed/sold 54,000 options to buy
@ $16.91, valued at
$913.1k
|
|
| 01/26/2021 |
4
| Nader Francois (Director) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Unknown transaction of 23,747 shares
@ $0
Disposed/sold 133,447 options to buy
@ $2.81, valued at
$375k
Disposed/sold 32,000 options to buy
@ $10.26, valued at
$328.3k
Disposed/sold 17,000 options to buy
@ $16.98, valued at
$288.7k
|
|
| 01/26/2021 |
4
| Schwartz Kira M. (General Counsel) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Disposed/sold 100,000 options to buy
@ $16.68, valued at
$1.7M
|
|
| 01/26/2021 |
4
| Sevigny Jeffrey (Chief Medical Officer) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Disposed/sold 400,342 options to buy
@ $0.18, valued at
$72.1k
Disposed/sold 122,439 options to buy
@ $10.26, valued at
$1.3M
Disposed/sold 89,000 options to buy
@ $16.91, valued at
$1.5M
|
|
| 01/26/2021 |
4
| Sheng Morgan (Director) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Disposed/sold 20,000 options to buy
@ $10.62, valued at
$212.4k
Disposed/sold 17,000 options to buy
@ $16.98, valued at
$288.7k
|
|
| 01/26/2021 |
4
| Nussbaum Ran (Director) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Unknown transaction of 1,576,881 shares
@ $0
Disposed/sold 17,000 options to buy
@ $16.98, valued at
$288.7k
|
|
| 01/26/2021 |
4
| GORDON CARL L (10% Owner) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Unknown transaction of 13,822,463 shares
@ $0
Disposed/sold 17,000 options to buy
@ $16.98, valued at
$288.7k
|
|
| 01/26/2021 |
4
| Thompson Peter A. (10% Owner) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Unknown transaction of 13,822,463 shares
@ $0
Disposed/sold 17,000 options to buy
@ $16.98, valued at
$288.7k
|
|
| 01/22/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 01/22/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 01/22/2021 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 01/22/2021 |
4
| Tyto Acquisition Corp (10% Owner) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Bought 34,284,789 shares
@ $22.5, valued at
$771.4M
|
|
| 01/22/2021 |
8-K
| Resignation/termination of a director |
| 01/22/2021 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 01/22/2021 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 01/22/2021 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 01/20/2021 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 01/20/2021 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 01/14/2021 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 01/14/2021 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
|